---
figid: PMC2586109__nihms-76803-f0001
figlink: /pmc/articles/PMC2586109/figure/F1/
number: F1
caption: PKCβII activates the Wnt/APC/β-catenin proliferative signaling pathway by
  inactivating GSK-3β and increasing the levels of β-catenin (). PKCβII also induces
  resistance to the growth inhibitory effects of TGFβ via a PKCβII→Cox-2→TGFβRII signaling
  pathway in vitro and in vivo (; ). Finally, PKCβII induces Ras activation thereby
  inducing an invasive phenotype in vitro ().
pmcid: PMC2586109
papertitle: Protein kinase C isozymes as therapeutic targets for treatment of human
  cancers.
reftext: Alan P. Fields, et al. Adv Enzyme Regul. ;48:166-178.
pmc_ranked_result_index: '70220'
pathway_score: 0.9438282
filename: nihms-76803-f0001.jpg
figtitle: Protein kinase C isozymes as therapeutic targets for treatment of human
  cancers
year: ''
organisms:
- Mus musculus
- Rattus norvegicus
- Lambdavirus lambda
- Homo sapiens
ndex: 7d7a95f7-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2586109__nihms-76803-f0001.html
  '@type': Dataset
  description: PKCβII activates the Wnt/APC/β-catenin proliferative signaling pathway
    by inactivating GSK-3β and increasing the levels of β-catenin (). PKCβII also
    induces resistance to the growth inhibitory effects of TGFβ via a PKCβII→Cox-2→TGFβRII
    signaling pathway in vitro and in vivo (; ). Finally, PKCβII induces Ras activation
    thereby inducing an invasive phenotype in vitro ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - GSK3B
  - MAP2K2
  - MAP2K1
  - HRAS
  - COL2A1
  - NRAS
  - MAPK3
  - CTNNB1
  - MAPK1
  - RAC1
  - APC
  - PRKCI
  - 0-3 fatty acids
  - fatty acids
  - Cancer
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AOM
  symbol: AOM
  source: hgnc_prev_symbol
  hgnc_symbol: COL2A1
  entrez: '1280'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: PKCI
  symbol: PKCI
  source: hgnc_alias_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
chemicals:
- word: 0-3 fatty acids
  source: MESH
  identifier: D005227
- word: fatty acids
  source: MESH
  identifier: D005227
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2586109__F1
redirect_from: /figures/PMC2586109__F1
figtype: Figure
---
